相关实验视频

Updated: Jun 24, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

脂质纳米颗粒和多重复纳米细胞的全面评估,以提供肌肉向的mRNA

Xuan Du¹, Erica Yada^1,2, Yuki Terai¹

¹Department of Biofunction Research, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), Tokyo 101-0062, Japan.

|September 28, 2023

概括

多复合纳米细胞为mRNA疗法提供持续的蛋白质生产和减少炎症,而脂质纳米粒子 (LNP) 为疫苗提供理想的快速表达,指导优化传递系统的开发.

科学领域:

生物技术是生物技术.
纳米医学是一种纳米医学.
药物运输药物运输药物运输

背景情况:

使者RNA (mRNA) 疗法在治疗癌症,传染病和遗传疾病方面越来越重要.
脂质纳米颗粒 (LNP) 对mRNA传递具有前景,但面临毒性和免疫性方面的挑战.
有效和安全的输送系统对于推进基于mRNA的疗法至关重要.

研究的目的:

为了比较新型多复合纳米细胞与已建立的脂质纳米颗粒 (LNPs) 交付mRNA的性能.
评估关键参数,包括输送效率,器官毒性,肌肉损伤,免疫反应和疼痛.
为了确定每个载体对于特定治疗应用的适用性.

主要方法:

开发和描述一种基于阴离子聚合物的纳米细胞载体 (PEG-PAsp(DET)).
在临床前模型中对纳米细胞和LNP (SM-102) 的比较分析.
评估蛋白质表达动力学,炎症标志物,组织损伤和免疫反应.

主要成果:

纳米细胞显示持续的蛋白质生产和较低的炎症,表明治疗潜力.
脂质纳米颗粒显示出快速的mRNA表达和强烈的免疫反应,适合疫苗.
纳米细胞和LNP之间在安全性和疗效性方面观察到不同的特征.

结论:

多复合纳米细胞和LNP在mRNA输送应用中具有不同的强度.
纳米细胞对于需要持续效果和减少炎症的治疗应用具有前景.
由于LNP能够引起快速和强烈的免疫反应,因此对疫苗开发有利.
这些发现支持针对特定医疗需求量身定制的mRNA输送系统优化.

关键词:

脂质纳米粒子 (LNP) 是一种传递器RNA (mRNA) 是一种多重复的纳米微粒.

更多相关视频

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

相关概念视频

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...